Lack of information on gender differences in the package inserts of prescription drugs in Japan-Reference-Cited by-同舟云学术

Lack of information on gender differences in the package inserts of prescription drugs in Japan

Published:2023-12-31 Issue:6 Volume:17 Page:396-403
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Maida Narumi¹,Kondo Shingo¹,Ogawa Masanori²,Hayashi Naoko³,Iwata Hiroki¹,Kobayashi Noriko¹,Yamaura Katsunori¹

Affiliation:

1. Division of Social Pharmacy, Center for Social Pharmacy and Pharmaceutical Care Sciences, Faculty of Pharmacy, Keio University, Tokyo, Japan.

2. Medi Pharm Co., Ltd., Tokyo, Japan.

3. Keio University Community Pharmacy, Tokyo, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/17/6/17_2023.01093/_pdf

Reference14 articles.

1. 1. Zopf Y, Rabe C, Neubert A, Gassmann KG, Rascher W, Hahn EG, Brune K, Dormann H. Women encounter ADRs more often than do men. Eur J Clin Pharmacol. 2008; 64:999-1004.

2. 2. Yu Y, Chen J, Li D, Wang L, Wang W, Liu H. Systematic analysis of adverse event reports for sex differences in adverse drug events. Sci Rep. 2016; 6:24955.

3. 3. Mauvais-Jarvis F, Berthold HK, Campesi I, Carrero JJ, Dakal S, Franconi F, Gouni-Berthold I, Heiman ML, Kautzky-Willer A, Klein SL, Murphy A, Regitz-Zagrosek V, Reue K, Rubin JB. Sex- and gender-based pharmacological response to drugs. Pharmacol Rev. 2021; 73:730-762.

4. 4. U. S. Department of Health, Education and Welfare, Food and Drug Administration. General considerations for the clinical evaluation of drugs. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-considerations-clinical-evaluation-drugs. (accessed October 5, 2023).

5. 5. Public Health Service Task Force on Women's Health Issues. Women's health: Report of the Public Health Service Task Force on Women's Health Issues, volume I. Public Health Rep. 1985;100:73-106.